Shandong Buchang Pharmaceuticals Co Ltd Tangible Net Worth Ratio
Shandong Buchang Pharmaceuticals Co Ltd tangible net worth ratio. Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Tangible Net Worth Ratio of 73.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥2.63 Billion) from net assets (CN¥10.07 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 603858 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Tangible net worth ratio of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 73.9%, reflecting net assets of CN¥10.07 Billion with intangible assets of CN¥2.63 Billion CNY. See how liquid is Shandong Buchang Pharmaceuticals Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Shandong Buchang Pharmaceuticals Co Ltd Tangible Net Worth Ratio by Year (2011–2024)
Shandong Buchang Pharmaceuticals Co Ltd tangible net worth ratio by year from 2011 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Shandong Buchang Pharmaceuticals Co Ltd market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.7% | CN¥9.81 Billion | CN¥2.49 Billion | CN¥19.33 Billion | ▼ -4.9 pp |
| 2023 | 79.6% | CN¥11.38 Billion | CN¥2.33 Billion | CN¥20.89 Billion | ▼ -2.6 pp |
| 2022 | 82.2% | CN¥12.28 Billion | CN¥2.19 Billion | CN¥21.95 Billion | ▼ -3.0 pp |
| 2021 | 85.2% | CN¥14.45 Billion | CN¥2.14 Billion | CN¥23.99 Billion | ▲ +0.5 pp |
| 2020 | 84.7% | CN¥13.81 Billion | CN¥2.11 Billion | CN¥22.89 Billion | ▼ -0.9 pp |
| 2019 | 85.6% | CN¥13.79 Billion | CN¥1.98 Billion | CN¥21.19 Billion | ▲ +0.3 pp |
| 2018 | 85.3% | CN¥13.86 Billion | CN¥2.04 Billion | CN¥20.03 Billion | ▲ +0.6 pp |
| 2017 | 84.7% | CN¥13.22 Billion | CN¥2.02 Billion | CN¥19.20 Billion | ▼ -0.2 pp |
| 2016 | 84.9% | CN¥12.71 Billion | CN¥1.92 Billion | CN¥18.67 Billion | ▲ +11.4 pp |
| 2015 | 73.5% | CN¥7.26 Billion | CN¥1.92 Billion | CN¥15.76 Billion | ▼ -11.2 pp |
| 2014 | 84.7% | CN¥4.45 Billion | CN¥680.91 Million | CN¥9.10 Billion | ▼ -2.0 pp |
| 2013 | 86.7% | CN¥4.28 Billion | CN¥569.03 Million | CN¥6.94 Billion | ▼ -4.7 pp |
| 2012 | 91.4% | CN¥4.02 Billion | CN¥346.96 Million | CN¥5.67 Billion | ▲ +0.1 pp |
| 2011 | 91.3% | CN¥2.80 Billion | CN¥244.55 Million | CN¥4.44 Billion | — |